|
시장보고서
상품코드
1986438
기계식 인공호흡기 시장 보고서 : 제품 유형, 인터페이스, 연령층, 환기 모드, 최종 용도 및 지역별(2026-2034년)Mechanical Ventilators Market Report by Product Type, Interface, Age Group, Mode of Ventilation, End-Use, and Region 2026-2034 |
||||||
세계의 기계식 인공호흡기 시장 규모는 2025년에 59억 달러에 이르렀습니다. IMARC Group은 2034년까지 시장 규모가 83억 달러에 이르고, 2026-2034년 CAGR 3.70%를 나타낼 것으로 예측했습니다. 이 시장의 주요 성장 요인으로는 만성폐쇄성폐질환(COPD) 및 호흡기 질환의 유병률 증가, 고혈압, 당뇨병, 심혈관 질환 환자 증가, 비침습적 및 휴대용 기계식 인공호흡기 개발 등 지속적인 기술 발전이 꼽힙니다.
만성 호흡기 질환 환자 증가
천식, 급성폐쇄성폐질환, 폐렴 등 만성 호흡기 질환 증가가 기계식 인공호흡기 시장 통계를 주도하고 있습니다. 또한, 전 세계적인 코로나19 팬데믹으로 인해 사망률, 이환율, 의료비용이 증가하여 시장 성장을 가속하고 있습니다. 따라서 여러 의료기관에서는 이러한 호흡기 질환의 발생을 최소화하기 위해 감염 대책과 예방에 중점을 두고 있습니다. 예를 들어, 미국 노인위원회(National Council on Aging)의 자료에 따르면, 불규칙한 호흡과 뇌에 산소 공급 감소를 특징으로 하는 폐쇄성 수면무호흡증(OSA)은 미국에서 약 3,900만 명의 성인이, 전 세계적으로 약 9억 3,600만 명이 앓고 있는 것으로 추정됩니다. 또한, 미국 폐협회에 따르면 만성폐쇄성폐질환(COPD)은 미국 내 질병별 사망 원인 중 3위를 차지하고 있습니다. 1,640만 명 이상이 만성폐쇄성폐질환 진단을 받았습니다.
기술 발전
기계식 인공호흡기의 휴대성, 모드, 사용자 인터페이스의 개선 등 지속적인 기술 발전으로 기계식 인공호흡기 시장이 확대되고 있습니다. 또한, 재택의료의 새로운 트렌드에 따라 가정환경에서 휴대가 간편하고 사용하기 쉬운 기기의 인기가 높아지면서 세계 시장을 주도하고 있습니다. 이 외에도 자동화 기능과 고도화된 모니터링 기능을 갖춘 스마트 기계식 인공호흡기의 도입도 시장 성장에 긍정적인 영향을 미치고 있습니다. 예를 들어, Max Ventilator는 가습기 및 산소 요법 기능을 갖춘 비침습적 기계식 인공호흡기를 출시하여 성인 및 신생아 치료에 폭넓은 용도를 보여주었습니다. 또한, 니혼코덴 오렌지메드는 비침습형이며, 응급 시 호흡을 돕는 'NKV-330 기계식 인공호흡기 시스템'에 대해 미국 FDA의 승인을 획득했습니다.
정부 주도 이니셔티브 시작
호흡기 질환과 조기 발견 및 치료의 중요성에 대한 인식 제고를 위한 공중보건 캠페인 등 각국 정부 기관에서 시행하고 있는 다양한 조치와 노력은 기계식 인공호흡기 시장 전망에 긍정적인 영향을 미치고 있습니다. 이와 더불어, 최신 및 개선된 기계식 인공호흡기 도입에 사용되는 연구개발에 대한 규제 당국의 투자 확대도 시장 확대에 기여하고 있습니다. 또한, 의료 인프라의 발전과 더불어 의료 종사자를 위한 교육 프로그램 및 세미나 증가는 기계식 인공호흡기 시장의 수익을 더욱 촉진하고 있습니다. 예를 들어, CAIRE의 'FreeStyle Comfort' 휴대용 산소 농축기는 프랑스와 독일에서 보험 적용이 승인되어 환자의 접근성이 향상되었습니다. 이번 제품 출시로 회사는 산소 요법 제품 포트폴리오를 확장했습니다. 또한, CorVent Medical은 CE 마크 승인을 획득하고 유럽에서 'RESPOND-19' 기계식 인공호흡기의 상업적 판매를 시작했습니다. 이 혁신적인 시스템은 사용 편의성과 집중치료용 인공호흡기 용량을 유연하게 확장할 수 있도록 설계되어 병원이 급성 호흡곤란 증후군(ARDS)을 앓고 있는 중증 환자들의 치료를 개선할 수 있도록 지원합니다.
The global mechanical ventilators market size reached USD 5.9 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 8.3 Billion by 2034, exhibiting a growth rate (CAGR) of 3.70% during 2026-2034. The market is primarily driven by the rising prevalence of chronic obstructive pulmonary disease (COPD) and respiratory disorders, the elevating number of individuals suffering from hypertension, diabetes, and cardiovascular diseases, and the continuous technological advancements, such as the development of non-invasive and portable mechanical ventilators.
Increasing Cases of Chronic Respiratory Conditions
The rising cases of chronic respiratory conditions, including asthma, acute obstructive pulmonary disease, and pneumonia are primarily driving the mechanical ventilators market statistics. Moreover, the outbreak of the COVID-19 pandemic across the globe had increased mortality, morbidity, and healthcare costs, which is propelling the market growth forward. Therefore, various medical facilities are focusing highly on control measures and infection prevention to minimize the cases of such respiratory diseases. For instance, the National Council on Aging data indicated that Obstructive Sleep Apnea (OSA), characterized by irregular breathing and reduced oxygen supply to the brain, affected about 39 million adults in the U.S. and an estimated 936 million globally. Additionally, as per the American Lung Association, chronic obstructive pulmonary disease (COPD) is the third leading cause of death by disease in the United States. More than 16.4 million people have been diagnosed with chronic obstructive pulmonary disease.
Technological Advancements
The ongoing technological advances, such as improved ventilator portability, modes, and user interfaces, are augmenting the mechanical ventilators market. Moreover, the growing popularity of portable and user-friendly devices in home settings, on account of the emerging trend of home-based medical care, is catalyzing the global market. Besides this, the introduction of smart mechanical ventilator variants with automated features and advanced monitoring capabilities is also positively influencing the market growth. For example, Max Ventilator introduced non-invasive ventilators featuring humidifiers and oxygen therapy capabilities, demonstrating versatility in applications for adult and neonatal care. Additionally, Nihon Kohden OrangeMed, Inc. received U.S. FDA clearance for the NKV-330 Ventilator System, which is non-invasive and provides respiratory support in emergencies.
Launch of Government Initiatives
The launch of several policies and initiatives by government bodies across countries, including public health campaigns to raise awareness about respiratory illnesses and the importance of early detection and treatment is positively influencing the mechanical ventilators market outlook. In addition to this, the inflating investments by regulatory authorities in research and development efforts for the introduction of the latest and improved mechanical ventilators are also propelling the market expansion. Moreover, the advancing healthcare infrastructures, along with the increasing number of training programs and seminars for medical professionals are further catalyzing the mechanical ventilators market revenue. For instance, CAIRE Inc.'s FreeStyle Comfort portable oxygen concentrator was authorized for reimbursement in France and Germany, enhancing patient access. The company extended its oxygen therapy modalities product portfolio through this launch. Furthermore, CorVent Medical received CE Mark approval and launched commercial use of its RESPOND-19 Ventilator in Europe. The novel system is designed for easy-to-use, flexible expansion of critical care ventilation capacity to allow hospitals to improve the treatment of critically ill patients suffering from acute respiratory distress syndrome (ARDS).
Intensive care ventilators are developed for usage in critical care settings, such as intensive care units (ICUs) and emergency departments. They are capable of offering an advanced respiratory support to patients with severe respiratory failure or other critical conditions. On the other hand, portable/ambulatory ventilators are designed for use outside of traditional hospital settings, including in-home care, ambulances, or other transport settings. They are smaller, lighter, and more portable than intensive care variants, making them suitable for use in various places.
Invasive ventilation typically comprises the insertion of a tube into the patient's airway, usually through the mouth or nose (endotracheal tube) or via a surgical opening in the neck (tracheostomy tube). This allows the ventilator to deliver air or oxygen directly into the lungs. Invasive ventilation is generally utilized for patients with severe respiratory failure or who are unable to breathe on their own. Moreover, non-invasive ventilation does not need the insertion of a tube into the airway of the individual. Instead, it uses a mask or similar device to deliver air or oxygen to the patient's lungs. Non-invasive ventilation is often used for patients with less severe respiratory failure or for patients who are able to breathe on their own but require the additional support.
Pediatric ventilators are specifically created for infants and children. They are smaller in size and have features that cater to the unique respiratory needs of pediatric patients. These devices often include specialized modes and settings to deliver the appropriate level of support for smaller lungs and airways. Besides this, adult ventilators are designed for use in adult patients. They are larger and more robust than pediatric derivatives and are capable of providing the higher tidal volumes and pressures demanded for adult respiratory support. On the other hand, geriatric patients, who are typically older adults, may require ventilator support, owing to age-related respiratory conditions or complications.
Combined mode of ventilation, also referred to as dual or hybrid mode, combines the aspects of volume and pressure ventilation. It allows the ventilator to adjust the inspiratory pressure to maintain a set tidal volume, providing a more flexible and adaptable ventilation. Moreover, in volume mode of ventilation, the ventilator supplies a set tidal volume to the patient with each breath. This mode is commonly used in patients with normal lung compliance or when precise control over tidal volume is required, such as in acute respiratory distress syndrome (ARDS). Besides this, in pressure mode of ventilation, the ventilator delivers a set inspiratory pressure to the individual, allowing for a more variable tidal volume based on the lung compliance and resistance of the patient.
In hospitals and clinics, mechanical ventilators are utilized in intensive care units (ICUs), emergency departments, operating rooms, and general wards to support patients with acute respiratory failure, respiratory distress, or other conditions that require assisted ventilation. Additionally, these devices are increasingly being used in homecare settings to provide long-term respiratory support to patients with chronic respiratory conditions, such as chronic obstructive pulmonary disease (COPD), neuromuscular disorders, or spinal cord injuries. Furthermore, ambulatory care centers, also known as outpatient clinics or day surgery centers, may utilize mechanical ventilators for patients undergoing procedures that require sedation or anesthesia, including endoscopic procedures or minor surgeries.
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.
North America represents a significant region of the mechanical ventilators market overview, owing to its advanced healthcare infrastructure and the inflating medical expenditures of individuals. Besides this, the increasing focus of Europe on healthcare quality and patient safety is further catalyzing the market forward. Moreover, in the Asia Pacific region, the rising aging population is positively influencing the market growth. Besides this, the inflating medical care spending by individuals in Latin America and Middle East and Africa and the increasing awareness towards respiratory diseases are augmenting the market expansion. For instance, according to a report published by the Centers for Disease Control and Prevention (CDC), out of all the hospitalizations caused by COVID-19, over 53% of patients were admitted to the intensive care unit. Additionally, based on a research study by Silvio A. Namendys-Silva et al., published in Critical Care, in Mexico, about 15.3% of hospitalized patients require invasive mechanical ventilation (IMV), and 70.8% of patients receive invasive mechanical ventilation (IMV) outside the ICU.
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the major market players in the Mechanical Ventilators industry include:
()